Beyond Sleepless Nights: Integrating Neurobiology, Clinical Burden, And Emerging Therapeutic Advances In Insomnia: A Comprehensive Evidence-Based Review

Figure 1 Epidemiology of Insomnia

 3. CLASSIFICATION OF INSOMNIA

Insomnia is a heterogeneous sleep disorder with diverse clinical presentations, durations, and underlying causes. A clear classification is essential for accurate diagnosis, appropriate treatment selection, and improved patient outcomes. Contemporary classification systems recognize insomnia as a disorder that may occur independently or coexist with other medical, psychiatric, or sleep-related conditions. The two most widely accepted classification systems are the International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR) and the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR).

Based on the duration of symptoms, insomnia is commonly categorized as short-term (acute) or chronic. Short-term insomnia typically develops in response to identifiable stressors such as illness, emotional distress, travel, or major life events and generally resolves once the precipitating factor subsides. In contrast, chronic insomnia is characterized by persistent sleep disturbances occurring on a regular basis for an extended period and is often maintained by a combination of biological, psychological, and behavioral factors. Chronic insomnia usually requires structured clinical evaluation and evidence-based interventions.

From an etiological perspective, insomnia may be associated with medical disorders, psychiatric illnesses, medication use, substance consumption, circadian rhythm disturbances, or environmental factors. However, current diagnostic frameworks emphasize that chronic insomnia should be considered a distinct clinical disorder even when it coexists with other health conditions, as effective treatment of insomnia may improve overall health outcomes and quality of life.

Clinically, insomnia may present as difficulty initiating sleep (sleep-onset insomnia), difficulty maintaining sleep with frequent awakenings (sleep-maintenance insomnia), or early morning awakening with an inability to return to sleep. Many patients experience a combination of these symptoms, highlighting the multifaceted nature of the disorder.

The ICSD-3-TR classifies insomnia primarily into chronic insomnia disorder, short-term insomnia disorder, and other insomnia disorder, while the DSM-5-TR defines insomnia disorder based on persistent sleep complaints associated with clinically significant daytime impairment. Although these systems differ slightly in terminology, both emphasize symptom persistence, adequate opportunity for sleep, and the exclusion of insufficient sleep as the primary cause of symptoms.

Recognizing the specific type and underlying contributors to insomnia is fundamental for selecting appropriate therapeutic strategies, predicting prognosis, and preventing long-term complications.

Abbreviations: ICSD-3-TR, International Classification of Sleep Disorders, Third Edition, Text Revision; DSM-5-TR, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision.

Table 1. Classification of Insomnia

4. PATHOPHYSIOLOGY OF INSOMNIA

Insomnia is a complex disorder resulting from the interaction of neurobiological, psychological, behavioral, and environmental factors. Rather than being caused by a single abnormality, chronic insomnia is now understood as a disorder of persistent hyperarousal, in which the brain and body remain in an increased state of activation during both wakefulness and sleep. This state interferes with normal sleep initiation, sleep maintenance, and the restorative functions of sleep

Figure 2: Pathophysiology of Insomnia

4.1 Hyperarousal Theory

The hyperarousal model is the most widely accepted explanation for chronic insomnia. Individuals with insomnia often exhibit increased physiological, cognitive, and emotional arousal that persists throughout the day and night. Excessive worrying, heightened stress responses, increased sympathetic nervous system activity, and elevated metabolic activity in the brain contribute to difficulty falling asleep and frequent nocturnal awakenings. Neuroimaging studies have demonstrated that certain brain regions remain more active during sleep in individuals with chronic insomnia than in healthy sleepers, supporting the concept of continuous central nervous system hyperactivation.

4.2 Neurotransmitter Dysregulation

Normal sleep depends on a delicate balance between sleep-promoting and wake-promoting neurotransmitters. Disruption of this balance plays a central role in the development of insomnia.

The inhibitory neurotransmitter γ-aminobutyric acid (GABA) promotes sleep by suppressing neuronal excitability. Reduced GABAergic activity may contribute to increased cortical arousal and impaired sleep initiation. In contrast, wake-promoting neurotransmitters such as orexin (hypocretin), norepinephrine, dopamine, histamine, and acetylcholine maintain alertness and wakefulness. Excessive activation of these systems may prolong wakefulness and fragment sleep.

Other neurotransmitters, including serotonin, melatonin, glutamate, and adenosine, also participate in regulating the sleep–wake cycle. Alterations in their physiological functions may further impair sleep continuity and circadian regulation.

4.3 Circadian Rhythm Dysregulation

The circadian rhythm is regulated by the suprachiasmatic nucleus (SCN) of the hypothalamus, which synchronizes the sleep–wake cycle with the external light–dark environment. Disruption of circadian timing due to shift work, jet lag, irregular sleep schedules, or excessive evening exposure to artificial light may delay sleep onset and reduce sleep quality. Altered melatonin secretion further contributes to circadian misalignment and chronic sleep disturbances.

4.4 Hypothalamic–Pituitary–Adrenal (HPA) Axis Activation

Psychological stress is an important precipitating factor for insomnia. Persistent activation of the HPA axis increases the secretion of cortisol and stimulates sympathetic nervous system activity. Elevated nighttime cortisol levels may interfere with normal sleep initiation, reduce slow-wave sleep, and promote repeated awakenings during the night. Sustained HPA axis activation is considered one of the biological mechanisms responsible for maintaining chronic insomnia.

4.5 Cognitive and Behavioral Mechanisms

Maladaptive cognitive processes play an important role in perpetuating insomnia. Many individuals develop excessive concern about sleep, unrealistic expectations regarding sleep duration, and anxiety related to the consequences of poor sleep. These negative beliefs increase emotional arousal and create a cycle in which attempts to sleep paradoxically make sleep more difficult.

Behavioral factors such as irregular bedtime schedules, prolonged daytime napping, excessive caffeine intake, nighttime screen exposure, and spending excessive time awake in bed further reinforce chronic insomnia by disrupting normal sleep regulation.

4.6 The 3P Model of Insomnia

The 3P Model, proposed by Arthur Spielman, provides a useful framework for understanding the development and persistence of insomnia. According to this model, insomnia results from the interaction of:

• Predisposing factors: Genetic susceptibility, personality traits, advanced age, female sex, and heightened physiological reactivity.
• Precipitating factors: Psychological stress, acute illness, pain, hospitalization, bereavement, or major life events.
• Perpetuating factors: Maladaptive sleep habits, dysfunctional beliefs about sleep, excessive time spent in bed, and persistent sleep-related anxiety.

Initially, insomnia is triggered by precipitating events; however, perpetuating factors often maintain the disorder even after the original stressor has resolved.

Table 2. Major Pathophysiological Mechanisms of Insomnia

5. RISK FACTORS FOR INSOMNIA

Insomnia is a multifactorial disorder that develops through the interaction of biological, psychological, behavioral, environmental, and medical factors. Although transient sleep disturbances may occur in response to temporary stressors, persistent exposure to multiple risk factors substantially increases the likelihood of developing chronic insomnia. Identification of these factors is essential for early intervention, prevention, and individualized treatment planning.

5.1 Biological Factors

Several biological characteristics influence an individual's susceptibility to insomnia. Increasing age is associated with alterations in sleep architecture, including reduced slow-wave sleep, frequent nocturnal awakenings, and decreased sleep efficiency. Women are more frequently affected than men, partly because of hormonal fluctuations during the menstrual cycle, pregnancy, postpartum period, and menopause. Genetic predisposition has also been implicated, suggesting that inherited variations in sleep regulation and stress responsiveness may contribute to insomnia in susceptible individuals.

5.2 Psychological Factors

Psychological conditions are among the strongest contributors to insomnia. Persistent stress, anxiety, depression, excessive worrying, emotional distress, and maladaptive coping mechanisms commonly interfere with normal sleep. Individuals who exhibit heightened emotional reactivity or cognitive hyperarousal often experience difficulty initiating or maintaining sleep. Negative beliefs about sleep and fear of not sleeping may further perpetuate the disorder.

5.3 Lifestyle and Behavioral Factors

Modern lifestyle habits have significantly contributed to the increasing prevalence of insomnia. Irregular sleep schedules, prolonged exposure to electronic devices before bedtime, excessive caffeine or nicotine consumption, inadequate physical activity, and daytime napping may disrupt normal sleep regulation. Poor sleep hygiene, such as using the bed for work or entertainment, inconsistent bedtime routines, and sleeping in unsuitable environments, further increases the risk of chronic insomnia.

5.4 Medical and Psychiatric Disorders

Numerous medical conditions are associated with insomnia. Chronic pain disorders, cardiovascular diseases, respiratory illnesses, gastroesophageal reflux disease, endocrine disorders, neurological diseases, and cancer frequently impair sleep quality. Psychiatric disorders, particularly anxiety disorders, depression, bipolar disorder, post-traumatic stress disorder, and substance use disorders, are strongly associated with persistent insomnia. The relationship is often bidirectional, with each condition potentially exacerbating the other.

5.5 Medication- and Substance-Related Factors

Several medications may contribute to sleep disturbances as an adverse effect. Stimulants, corticosteroids, certain antidepressants, decongestants, and some bronchodilators may interfere with sleep initiation or maintenance. Excessive consumption of caffeine, nicotine, alcohol, and recreational substances may also disrupt normal sleep architecture and reduce overall sleep quality.

5.6 Environmental and Occupational Factors

Environmental conditions significantly influence sleep quality. Excessive noise, bright light, uncomfortable room temperature, and unsuitable sleeping environments may impair sleep continuity. Occupational factors such as rotating shift work, night duty, frequent international travel, and irregular working hours disrupt circadian rhythm synchronization and increase the likelihood of insomnia. Healthcare professionals, emergency workers, and shift-based employees are particularly vulnerable because of repeated circadian misalignment.

The coexistence of multiple risk factors substantially increases the probability of developing chronic insomnia. Consequently, a comprehensive clinical assessment should include evaluation of biological characteristics, psychological health, lifestyle habits, medical conditions, medication history, and environmental influences to facilitate individualized management and improve long-term treatment outcomes.

Table 3. Major Risk Factors Associated with Insomnia

6. CLINICAL MANIFESTATIONS OF INSOMNIA

The clinical presentation of insomnia extends beyond disturbed nocturnal sleep and encompasses a broad spectrum of daytime impairments that significantly affect an individual's physical, cognitive, emotional, and social functioning. Although the severity and pattern of symptoms vary among patients, persistent sleep disturbance accompanied by daytime consequences remains the hallmark of insomnia disorder.

6.1 Night-Time Symptoms

The primary symptoms of insomnia occur during the sleep period. Patients commonly report difficulty initiating sleep despite adequate opportunity to sleep, prolonged sleep latency, frequent nocturnal awakenings, difficulty returning to sleep after awakening, or waking earlier than intended. Many individuals also describe their sleep as light, fragmented, or non-restorative, even when the total sleep duration appears adequate.

The pattern of sleep disturbance may differ among individuals. Some patients predominantly experience difficulty falling asleep (sleep-onset insomnia), whereas others report repeated awakenings during the night (sleep-maintenance insomnia) or persistent early morning awakening. In chronic insomnia, these symptoms often occur several nights each week and may persist for months or years if left untreated.

6.2 Daytime Consequences

The effects of insomnia extend well beyond the nighttime period. Inadequate or poor-quality sleep frequently results in excessive daytime fatigue, reduced energy levels, impaired concentration, memory difficulties, decreased attention, and slower cognitive processing. These impairments may adversely affect academic performance, occupational productivity, and decision-making abilities.

Emotional disturbances are also common. Patients with insomnia frequently experience irritability, mood fluctuations, anxiety, frustration, and reduced stress tolerance. Persistent insomnia may contribute to the development or worsening of depressive symptoms and other mental health conditions.

6.3 Functional and Social Impact

Chronic insomnia significantly affects daily functioning and overall quality of life. Individuals often report reduced work efficiency, increased absenteeism, impaired interpersonal relationships, and decreased participation in social and recreational activities. Sleep deprivation also increases the risk of workplace errors, motor vehicle accidents, and occupational injuries because of impaired alertness and delayed reaction time.

In addition to its psychosocial consequences, chronic insomnia has been associated with adverse physical health outcomes, including impaired immune function, increased cardiovascular risk, metabolic disturbances, and reduced overall well-being. These widespread effects emphasize that insomnia should be recognized as a disorder affecting multiple dimensions of health rather than merely a complaint of poor sleep.

Timely recognition of both nocturnal and daytime symptoms is essential for accurate diagnosis, assessment of disease severity, and selection of appropriate therapeutic interventions.

Table 4. Clinical Manifestations of Insomnia

7. DIAGNOSIS OF INSOMNIA

Accurate diagnosis of insomnia is essential for identifying the underlying causes of sleep disturbance, distinguishing insomnia from other sleep disorders, and selecting appropriate treatment strategies. The diagnosis is primarily clinical and is based on a detailed sleep history, assessment of daytime impairment, and evaluation of contributing medical, psychiatric, behavioral, and environmental factors. Laboratory investigations are not routinely required unless another sleep disorder or underlying medical condition is suspected.

7.1 Clinical Assessment

A comprehensive clinical assessment is the cornerstone of insomnia diagnosis. The evaluation should include the onset, duration, frequency, and severity of sleep complaints, together with information regarding bedtime habits, sleep schedule, lifestyle factors, medication use, caffeine and alcohol intake, occupational history, and psychosocial stressors. Particular attention should be paid to the presence of daytime symptoms such as fatigue, impaired concentration, irritability, mood changes, and reduced work or academic performance.

Healthcare professionals should also screen for medical disorders, psychiatric illnesses, chronic pain, neurological diseases, respiratory disorders, and other sleep disorders that may contribute to insomnia or mimic its symptoms.

7.2 Diagnostic Criteria

The diagnosis of chronic insomnia is generally based on internationally accepted criteria. According to current clinical recommendations, insomnia is characterized by persistent difficulty in sleep initiation, sleep maintenance, or early morning awakening despite adequate opportunity for sleep, accompanied by significant daytime impairment. Symptoms should occur regularly over a prolonged period and should not be better explained by another untreated sleep disorder, substance use, or an underlying medical condition.

7.3 Sleep History and Sleep Diary

A detailed sleep history provides valuable information regarding sleep patterns and potential precipitating factors. Patients are often encouraged to maintain a sleep diary for one to two weeks, recording bedtime, wake-up time, sleep latency, nocturnal awakenings, total sleep duration, daytime naps, and factors that may influence sleep. Sleep diaries are inexpensive, non-invasive, and useful for monitoring treatment response.

7.4 Standardized Assessment Tools

Several validated questionnaires assist in evaluating insomnia severity and its impact on daily functioning.

• Insomnia Severity Index (ISI): Assesses the severity of insomnia symptoms and their effect on quality of life.
• Pittsburgh Sleep Quality Index (PSQI): Evaluates subjective sleep quality and sleep disturbances over the previous month.
• Epworth Sleepiness Scale (ESS): Measures excessive daytime sleepiness and is particularly useful when other sleep disorders are suspected.

These instruments complement, but do not replace, a comprehensive clinical assessment.

7.5 Actigraphy

Actigraphy involves the use of a wrist-worn device that continuously records body movements over several days or weeks. It provides objective information regarding sleep–wake patterns, sleep duration, and circadian rhythm disturbances in the patient's usual environment. Actigraphy is particularly useful in patients with irregular sleep schedules or suspected circadian rhythm sleep–wake disorders.

7.6 Polysomnography (PSG)

Polysomnography is the gold standard investigation for many sleep disorders; however, it is not routinely indicated for uncomplicated chronic insomnia. It is recommended when conditions such as obstructive sleep apnea, periodic limb movement disorder, parasomnias, or other complex sleep disorders are suspected. PSG records multiple physiological parameters during sleep, including brain activity, eye movements, muscle activity, heart rhythm, respiratory effort, oxygen saturation, and limb movements.

7.7 Differential Diagnosis

Several conditions may present with symptoms similar to insomnia and should be considered during evaluation. These include circadian rhythm sleep–wake disorders, obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder, narcolepsy, medication-induced sleep disturbances, and sleep problems secondary to psychiatric or neurological disorders. Identifying these conditions is essential because management strategies differ considerably.

A systematic diagnostic approach enables clinicians to identify contributing factors, assess symptom severity, and develop individualized treatment plans that address both the sleep disturbance and any associated comorbid conditions.

Table 5. Diagnostic Tools Used in the Evaluation of Insomnia

8. MANAGEMENT OF INSOMNIA

The primary goals of insomnia management are to improve sleep quality, reduce sleep latency, minimize nocturnal awakenings, restore daytime functioning, and enhance overall quality of life. Effective management requires an individualized approach that addresses the underlying causes, contributing factors, and patient-specific clinical characteristics. Current clinical guidelines recommend a combination of non-pharmacological and pharmacological interventions, with treatment selection based on symptom severity, duration of insomnia, comorbid conditions, patient preference, and potential treatment risks.

8.1 Treatment Goals

The principal objectives of insomnia treatment include:

• Improving sleep initiation and sleep maintenance.
• Increasing total sleep duration and sleep efficiency.
• Restoring normal daytime functioning and cognitive performance.
• Reducing fatigue, mood disturbances, and impaired quality of life.
• Identifying and treating underlying medical or psychiatric conditions.
• Preventing recurrence and minimizing dependence on hypnotic medications.

8.2 Non-Pharmacological Management

Non-pharmacological interventions are considered the first-line treatment for chronic insomnia because they provide sustained clinical benefits without the adverse effects associated with long-term medication use. These approaches target the behavioral, cognitive, and environmental factors that contribute to persistent sleep disturbances.

8.2.1 Cognitive Behavioral Therapy for Insomnia (CBT-I)

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the most effective evidence-based psychological treatment for chronic insomnia. It aims to modify maladaptive thoughts and behaviors that interfere with normal sleep while promoting healthy sleep habits.

The major components of CBT-I include:

• Cognitive restructuring to challenge dysfunctional beliefs about sleep.
• Stimulus control therapy.
• Sleep restriction therapy.
• Relaxation techniques.
• Sleep hygiene education.

Numerous clinical studies have demonstrated that CBT-I improves sleep latency, sleep efficiency, total sleep time, and daytime functioning, with benefits that are often maintained long after treatment has ended.

8.2.2 Sleep Hygiene Education

Sleep hygiene consists of behavioral and environmental practices that promote healthy sleep. Although sleep hygiene alone is usually insufficient for treating chronic insomnia, it forms an important component of comprehensive management.

Common sleep hygiene recommendations include:

• Maintaining a consistent bedtime and wake-up schedule.
• Avoiding caffeine, nicotine, and alcohol close to bedtime.
• Limiting screen exposure before sleep.
• Creating a quiet, dark, and comfortable sleeping environment.
• Engaging in regular physical activity while avoiding vigorous exercise immediately before bedtime.
• Avoiding heavy meals late in the evening.

8.2.3 Stimulus Control Therapy

Stimulus control therapy is designed to re-establish a strong association between the bed and sleep while reducing conditioned wakefulness.

Patients are advised to:

• Go to bed only when sleepy.
• Use the bed exclusively for sleep and sexual activity.
• Leave the bedroom if unable to sleep within approximately 20 minutes.
• Return to bed only when sleepiness develops.
• Wake up at the same time every morning.
• Avoid daytime napping whenever possible.

8.2.4 Sleep Restriction Therapy

Sleep restriction therapy aims to improve sleep efficiency by temporarily limiting the amount of time spent in bed to approximately match actual sleep duration. As sleep efficiency improves, time in bed is gradually increased under professional supervision. Although patients may initially experience increased daytime sleepiness, this approach has demonstrated significant long-term effectiveness in chronic insomnia.

8.2.5 Relaxation Therapy

Relaxation techniques reduce physiological and psychological arousal that interferes with sleep.

Common techniques include:

• Progressive muscle relaxation.
• Deep breathing exercises.
• Mindfulness meditation.
• Guided imagery.
• Biofeedback.

These interventions are particularly beneficial for individuals with stress-related insomnia or excessive pre-sleep anxiety.

Table 6. Non-Pharmacological Interventions for Insomnia